This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Elanco US Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Stephen Stirm
Introduction
Stephen Stirm is an accomplished inventor based in Indianapolis, IN. He has made significant contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitors. His work focuses on enhancing the efficacy and safety of these compounds through innovative formulations.
Latest Patents
Stephen Stirm holds a patent for "JAK inhibitors having a specific particle size distribution." This patent details compositions of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile, which possess a specific acceptance value and/or particle size distribution. The patent also includes pharmaceutical compositions comprising these compounds, methods of using them, and processes for their manufacture. He has 1 patent to his name.
Career Highlights
Stephen Stirm is currently employed at Elanco US Inc., where he continues to innovate in the pharmaceutical sector. His work at Elanco focuses on developing solutions that improve animal health and welfare through advanced therapeutic options.
Collaborations
Due to space constraints, the collaborations section has been omitted.
Conclusion
Stephen Stirm's contributions to the field of pharmaceuticals, particularly through his patent on JAK inhibitors, highlight his role as a key innovator in the industry. His work at Elanco US Inc. continues to pave the way for advancements in animal health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile